How brain myelin damage could lead to seizures in MS
Study may explain why some people living with multiple sclerosis experience epileptic seizures
New hope for MS
Scientists identify two compounds that could benefit people living with multiple sclerosis
Link found between mitochondria and MS brain damage
UC Riverside study could lead to new treatments addressing multiple sclerosis
Pandemic led to profound changes in multiple sclerosis clinical practice
UC Riverside-led national survey of MS specialists finds nearly 10% had been redeployed to the front lines of COVID-19 patient care
Remyelinating drug could improve vision in patients with multiple sclerosis
UC Riverside-led mouse study stresses MS treatment should be started early
Researchers explore why some MS patients experience seizures
UC Riverside study examines molecular pathways that may instigate seizures in some multiple sclerosis patients
More than half of American adults with advanced multiple sclerosis report mistreatment by caregivers
UC Riverside-led study describes first published survey documenting nature and extent of caregiver mistreatment of this population
Research offers superior therapeutic approach for MS
Multiple sclerosis is an autoimmune disease that affects more than 2.3 million people worldwide. This debilitating condition periodically shutters communication between the brain and other parts of the body, resulting in symptoms that range from numbness and tingling in the arms and legs to blindness and paralysis. While treatments are...